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Two novel oxidovanadium(IV) complexes with a new bidentate (O- and N-) imine-based ligand 2-((E)-(6-ﬂuorobenzo[d]thiazol-
2-ylimino)methyl)-6-methoxyphenol (HL) were synthesized under in situ experimental condition where VOSO4 acts as a kinetic
template in the ratio 2 :1 (L :M) and mixed ligand complex using 1,10-phenanthroline (phen) in 1 :1 :1 (L :M : phen) ratio. )e
synthesized compounds were structurally characterized by microanalysis, magnetic susceptibility, FTIR, electronic spectra,
TG/DTA, ESR, and molar conductance studies. Based on the spectral studies, the complexes have the general composition [VO
(L)2] (C1) and [VO(L)phen] (C2) in a square pyramid geometrical fashion. )e synthesized compounds were primarily screened
for their in vitro growth inhibiting activity against diﬀerent strains of bacteria, namely, E. coli, B. subtilis, S. aureus, and
P. aeruginosa by the disc diﬀusion method. Also, the antifungal activity was determined against C. albicans and A. niger by the
Bateman poisoned technique. )e in vitro antioxidant activity of all the compounds was determined by DPPH free radical-
scavenging assay. Intercalative mode of DNA-binding properties of the oxidovanadium(IV) complexes with calf-thymus DNA
(CT-DNA) was investigated using UV, ﬂuorescence spectra, and viscosity measurements.
1. Introduction
Vanadium compounds, especially the coordination chemistry
of oxidovanadium(IV), have aroused signiﬁcant interest for
several main reasons in recent years especially in the designing
of long-acting drugs in metabolism. Research interest in oxi-
dovanadium chemistry derives from its utility in several bi-
ological and industrial processes like antimicrobial, spermicidal,
antioxidant, antitumor, DNA binding [1], and recently as in-
sulin mimetic [2]. )e vital role of vanadium in diﬀerent
chemical and biological systems hasmotivated the development
of vanadium chemistry.)e coordination chemistry of nitrogen
and oxygen donor ligand is an active area of research. It is
evident that the –HC�N linkage in azomethine derivatives is an
essential structural requirement for biological activity [3, 4].)e
geometry, coordination number, and biological eﬃcacy of
oxidovanadium(IV) are highly ligand dependent. It is also
known that VO2+ is less toxic than the vanadate ion (VO43−)
and as shown above, with all these characteristics, the com-
plexes exhibit potential therapeutic applications [5].
In addition to that imine bases containing heterocyclic
nucleus have potent biological activity.
)e o-hydroxy imine bases have emerged as an antimi-
crobial agent of immense interest because of their compre-
hensive spectrum of in vitro and in vivo chemotherapeutic
action [3, 6]. )emetal complexes from bidentate ligand have
often been studied recently because of their technical appli-
cations in an enhancement of drug action. Transition metal
complexes of vanadium with imine bases have been amongst
the most widely studied of coordination compounds in the
past few years since they are found to be important as an-
alytical and antimicrobial agents. )e complexes formed by
3d metals with ligand using both oxygen and nitrogen have
been paid close attention in this area.
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Antioxidants interfere with the oxidative processes by
scavenging free radicals, chelating free catalytic metals, and by
acting as electron donors [7]. Interaction study of small
molecules with DNA attracts attention for importance in
cancer therapy and molecular biology [8]. DNA is involved in
many kinds of life processes, and consequently, it is considered
to be the prime target of drugs.e transitionmetal complexes
of 1,10-phenanthroline have been widely employed in DNA
studies due to their utility in biomedicinal chemistry and in the
design of stereospeci­c DNA-binding drugs [9]. In this per-
spective, it is essential to know the antioxidant and DNA
binding properties of bioactive compounds for their use in the
pharmaceutical and therapeutic ­eld.
e current study is structured to provide a synthesis and
characterization of a new imine-based ligand (HL) and its
oxidovanadium(IV) complexes. e new compounds have
been subjected to characterize by dierent analytical tech-
niques and also exploit some biological applications of
oxidovanadium complexes.
2. Experimental
2.1. Physical Measurements. All the solvents and reagents
procured commercially and were used without prior puri­-
cation. 2-Amino-6-uorobenzothiazole, 1,10-phenanthroline
monohydrate, and o-vanillin were purchased from Sigma-
Aldrich chemicals, Germany. VOSO4·6H2O and all other
solvents are procured from Merck Specialties Private Limited,
Mumbai. e melting point (temperature 0–350°C) of the
compounds was determined on an ELICO-3210 apparatus and
is uncorrected. FTIR spectra of the compounds were recorded
on a PerkinElmer 783 spectrophotometer via attenuated total
reection (FT-ATR) in the range of 4000–400 cm−1. Elemental
analyses (CHNO) were performed with a model 240 Perki-
nElmer elemental analyzer. UV-visible spectra of the com-
plexes in the region 200–800nmweremeasured using aUV-Vis
spectrophotometer (DU 730 “Life Science” M/S Beckman
coulter, USA). Molar conductance measurements were per-
formed for the prepared complexes using an Elico CM-180
conductometer with a cell having a cell constant 1. TGA
analysis was performed on a ShimadzuAT-50 thermal analyzer
from 30 to 900°C with a heating rate at 10°C/min under
N2 atmosphere. Electron spin resonance (ESR) spectra were
recorded using a JEOL JES-TE100 ESR spectrometer in DMSO
solution at a liquid-nitrogen temperature on X-band at a fre-
quency of 9.13 GHz under the magnetic ­eld of 300mT.
Ascorbic acid, CT-DNA, and ethidium bromide (EB) were
purchased from Sigma Corp., and they were used as received.
2.2. Methodology
2.2.1. Synthesis of Imine-Based Ligand (HL)
(1) Classical Method. e ligand HL was synthesized by the
condensation of 2-amino-6-uorobenzothiazole with o-vanillin
in 1 :1 ratio. To an absolute methanolic solution of 2-amino-6-
uorobenzothiazole (10mmol, 1.103g), themethanolic aromatic
aldehyde, that is, o-vanillin (10mmol, 1.521 g) was added and
the reaction mixture was then stirred under reux at 80°C
for 12 h. e product formed after slow evaporation of the
solvent was then isolated by ­ltration, washed, and recrys-
tallized from methanol. Yield 78–79%, and synthetic path-
way of ligand HL and its complexes is displayed in Scheme 1.
(2) Microwave Method. e title compound HL was synthe-
sized by placing an equimolar ratio of themixture of 2-amino-6-
uorobenzothiazole, and 2-hydroxy-m-anisaldehydewasmixed
thoroughly in a grinder. e reaction ask was then irradiated
in a microwave oven for 7min using dry methanol (3–4mL) as
a solvent. TLCwas used to assess the completion of the reaction
progress and to preliminary check on the purity of the product,
and the reaction mixture was allowed to attain room temper-
ature (25±2°C). e yellow solid was obtained after recrystal-
lization from methanol, and yield 87–89%.
(3) HL: 2-((E)-(6-Fluorobenzo[d]thiazol-2-ylimino)methyl)-
6-methoxyphenol. Mp 170–172°C; Rf 0.55, Anal. (%) for
C15H11FN2O2S: Found (calc.): C 54.80 (54.82), H 2.68 (2.63),
N 9.11 (9.13), O 5.21 (5.22);m/z 302.05Da; FTIR (υmax/cm−1);
(υOH) 3253, (HCN) azomethine 1662; 1H NMR (295K/δ
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Scheme 1: Synthetic route of ligand HL and its complexes.
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in ppm/DMSO-d6 400MHz): HC�N 9.776 (1H, s); phe-
nolic OH 11.45 (1H, s); Ar-H 7.0–7.9 (6H, m); 13C NMR
(295K/δ(ppm)/DMSO-d6 400MHz): 164.176, 123.880, 109.423,
158.848, 109.150, 148.414, 135.710, 161.261, 119.463, 159.63,
115.714, 135.323, 124.494, 129.215.
2.2.2. Synthesis of Complexes
(1) Preparation of Complex 1 [C1]. )e metal salt
(VOSO4·6H2O) (2mmol) was dissolved in 10mL of aqueous
alcoholic solution, ligand HL (4mmol) was mixed in 15mL
ethanol in the ratio of 1 : 2, and the reaction mixture was
reﬂuxed for 9 h on a water bath. After a speciﬁed period of
reaction, the solvent was evaporated slowly by allowing
standing at room temperature. )e resultant yellow color
complex was used for further characterization.
(2) Preparation of Complex 2 [C2]. Complex 2 was prepared by
mixing an equimolar ratio of metal salt (VOSO4·6H2O) in the
aqueous medium and an ethanolic solution of ligand HL, and
the mixture was stirred for 10min. 1,10-Phenanthroline
monohydrate dissolved in ethanol was added at the same
temperature. It was then kept under reﬂux for 8h on a water
bath.)en, the solvent was evaporated at RT, and the obtained
green color complex was used for further analysis.
(3) C1: [VO (L1)2]2. Yield� 65%, yellow color, Anal. (%) for
C30H20VF2N4O5S2; Found (Calc.) C 53.81 (53.02), H 3.01
(3.12), V 7.61 (7.59), N 8.37 (8.21), O 11.95 (12.05);
mp≥ 300°C. m/z: 669.02Da; IR (υmax/cm−1); (HC�N) azo-
methine 1640; M-O 542; M-N 463; 362, H2O 3387.
(4) C2: [VO(L1)(phen)]. Yield� 78%, green color, Anal. (%)
for C27H18VFN4O3S: Found (Calc.) C 59.13 (58.71), H 3.31
(3.14), V 9.29 (9.12), N 10.22 (10.55), O 8.75 (8.99);
mp≥ 300°C. m/z: 548.461Da; IR (υmax/cm−1); (HC�N)
azomethine 1633; M-O 576; M-N 468.
2.3. Bioassay Studies
2.3.1. Antimicrobial Activity. )e biological activities of the
compounds have been investigated to display the possibility
of their uses in the medicinal ﬁeld. )e in vitro antimicrobial
screening eﬀects of the synthesized compounds were tested
against four bacterial strains, namely, E. coli. (MTCC 443),
B. subtilis (MTCC 441), S. aureus (MTCC 96), and P. aer-
uginosa (MTCC 424) and two fungal species (A. nigerMTCC
282 and C. albicans MTCC 227). )e disc diﬀusion method
using the nutrient agar medium for antibacterial activity [10]
and Czapek’s agar nutrient medium was used for antifungal
activity by the Bateman poisoned technique [11]. )e bac-
teria and fungi were subcultured in the sterile autoclaved
medium and were incubated up to 24 h for bacteria (37±
2°C) and 72 h for fungi at 22± 1°C. Standard antibacterial
drug chloramphenicol and antifungal drug ﬂuconazole were
used for comparison. )e stock solution (1mg/mL) of the
test compounds was prepared in DMSO. )e antibiotic
activity of each compound was evaluated at three diﬀerent
concentrations on dilution of stock solution, namely, 10, 50,
and 100 µg/mL. )e discs having a diameter of 5mm were
soaked in the test solutions of the above three concentrations
and were placed on an appropriate nutrient medium pre-
viously seeded with organisms in the Petri dishes and stored
in an incubator at the abovementioned period. In order to
clarify any eﬀect of DMSO on the biological screening,
separate studies were carried out with solutions alone of
DMSO and they showed no activity against any microbial
strains. )e colony diameter of the test organism was
measured with the mm scale after a week. )e percentage
inhibition of the growth of the test organisms was calculated
by the Vincent equation:
growth inhibition percentage �
100 Cd −Td( )
Cd
, (1)
where Cd � colony diameter of the control plate and
Td � colony diameter of microbial growth on the test plate.
Biocidal activity was assessed by measuring minimum
inhibitory concentrations (MICs). )e MIC value of each
compound was determined at its lowest concentration
(highest dilution) required to arrest the growth of microbes
by the standard broth dilution assay. Compounds showing
promising antibacterial/antifungal activity were selected for
minimum inhibitory concentration (MIC) studies.
2.3.2. Time-Dependent Killing Kinetics. Time-dependent
killing kinetic analyses of compounds against E. coli strain
were performed at 0.5×, 1×, and 2× the MIC, as determined
previously, and an initial stock culture with a concentration of
1× 106 CFU per well. After incubation at the time interval of 6,
12, 18, and 24h at diﬀerent MICs of the compounds, the
absorbance was measured at 625nm. )e culture treated with-
out the compound was kept as the control. )e experiment
was performed in triplicate.)e rate and extent of killing were
expressed as mean log10·CFU·mL−1 against time [12].
2.3.3. Antioxidant Activity. DPPH has an odd electron
number with a strong absorption band at 517 nm.When this
electron becomes paired oﬀ, the absorption decreases
stoichiometrically with respect to the number of electrons
taken up [7, 13]. Such a change in the absorbance produced
in this reaction has been widely applied to test the capacity of
various molecules to act as free radical scavengers.)erefore,
DPPH is usually used as a substrate to evaluate antioxidant
activity of other antioxidants. )e present oxidovanadium
complexes are in the +4 oxidation state and act as an electron
donor compound. It can reduce the DPPH radical to DPPH
(α,α-diphenyl-β-picrylhydrazine) compound, and the VO
(IV) ion will be oxidized to its +5 state.
)e free radical-scavenging activity of the compounds
was measured in terms of hydrogen donating or radical-
scavenging ability using the stable radical DPPH described
by the Blois method [14]. Brieﬂy, stock solutions of the
samples (0.001 g/mL) were prepared by dissolving in DMSO.
Diﬀerent concentrations (20–100 µL) of the stock solution
were made up to 3mL of methanol. A solution of DPPH
Bioinorganic Chemistry and Applications 3
(0.0001mol) in methanol was prepared, and 1mL of this
solution was added to each of the above test solutions. 0.1M
sodium acetate buﬀer was added. )e mixture was shaken
vigorously and incubated for 30min, and then, the absor-
bance was measured at 517 nm. All the tests were carried out
in triplicate and expressed as the mean± standard deviation
(SD). Ascorbic acid (AA) was used as a standard or positive
control, parallel to the test compound and in the absence of
the test compound/standard used as the negative control.
)e capability to scavenge the DPPH radical was calculated
using the following equation:
I(%) �
Ac −Asample
Ac
( ) × 100, (2)
where the absorbance of the control reaction mixture ex-
cluding the test compounds is termed as Ac and the ab-
sorbance of the test compounds is Asample.
2.3.4. DNA-Binding Experiments
(1) Electronic Absorption Spectral Titration. )e stock solu-
tion of CT-DNA was prepared in 5mM Tris-HCl/50mM
NaCl buﬀer at pH 7, which gave A260/A280nm of ca. 1.8-1.9,
indicating that the DNA was suﬃciently devoid of protein
[15], and the concentration of DNA per nucleotide was de-
termined from its absorption intensity at 260 nmwith a known
molar absorption coeﬃcient (ε260� 6600dm3·M−1·cm−1) [16].
DNA stock solutions were kept stored at 4°C and used within
four days. )e binding constant (Kbin) values of the com-
plexes to CT-DNAwere obtained bymonitoring the changes
in the absorption of the spectral band intensity with in-
creasing DNA concentration. After equilibrium had been
achieved, the spectra were recorded at 200–550 nm against an
analogous solution of DNA as a reference. UV spectral data
were ﬁtted into the Wolfe–Shimmer equation (3) [17] to
obtain the intrinsic binding constant (Kbin)
[DNA]
εa − εb � [DNA]εb − εf + 1Kbin εb − εf( ), (3)
where [DNA] is the concentration of the DNA in base pairs,
εa is the apparent extinction coeﬃcient (Aobs/[MC]), εb is the
extinction coeﬃcient of themetal complex in the fully bound
form, and the extinction coeﬃcient for the free metal
complex [MC] is εf .)e value of intrinsicKbin was calculated
as the ratio of the slope to intercept. )e due correction was
made for the absorbance of DNA itself.
(2) EB Competition Assay. )e competitive binding activity
of oxidovanadium complexes with CT-DNA was studied by
the ﬂuorescence spectral method using emission intensity
of ethidium bromide (EB) with varying concentrations of
DNA. EB emits intense ﬂuorescence light in the presence of
DNA at λex 600 nm (546 nm) due to strong stacking in-
tercalation between adjacent DNA base pairs. )e ﬂuores-
cence emission intensity can be quenched when the second
molecule (synthesized compounds) was added to the CT-
DNA bound EB solution. In the ﬂuorescence quenching
study, [DNA]/[EB] � 1.13 is kept constant and varied with
the compound concentration. )e ﬂuorescence emission
spectra of the reaction mixture were recorded between 400
and 850 nm at excitation wavelength 350 nm. )e ﬂuores-
cence quenching eﬃciency is evaluated according to the
following classical Stern–Volmer equation:
Io
I
� 1 + ksvQ, (4)
where the ﬂuorescence intensities without and with the
quencher (complexes) are termed Io and I, respectively, “Q”
is the concentration of the quencher, and Ksv is the linear
Stern–Volmer quenching constant. )e measured ﬂuores-
cence intensities were corrected for the dilution and the
inner ﬁlter eﬀect in the entire DNA-binding experiments.
(3) Viscosity Measurements. Viscosity experiments were carried
on theUbbelohde viscometer at a static temperature (26±0.1°C).
Compounds were added to the DNA solution (10 µmol·L−1)
with amicropipette. Flow timewas recorded for the increasing
concentration of the compounds (0–10µM). Data were graph-
ically presented as (η/ηo)
1/3 versus the binding ratio of the
concentration of compounds to DNA (r), where η was
the viscosity of theDNA in the presence of the compound and
ηo was the viscosity of the DNA alone. )e relative viscosity η
was calculated using the following equation [18]:
η �
t− to( )
to
, (5)
where t and to represent the ﬂow time of the buﬀer solution
through the capillary and the observed ﬂow time for the
DNA in the presence and absence of the compounds, re-
spectively. )e mean of replicate measurements was used to
evaluate the viscosity of the samples.
3. Results and Discussion
3.1. Chemistry. All the synthesized compounds are stable
in the atmospheric condition, nonhygroscopic, insoluble in
water but slightly soluble in alcohol and readily soluble in
DMF and DMSO. Microwave-assisted synthesis of ligand
HL was easy, convenient, short reaction period with a good
yield (87–89%) and superior to the conventional method
(78–79%). Oxidovanadium complexes are highly colored,
ﬁne amorphous powder, stable in the solid phase at the
ambient temperature in the light.)e solutions were stable on
keeping for an extended period in the light.)e analytical and
physical data of the new compounds are summarized in the
experimental section. Analytical data show that the complexes
have the stoichiometry to be 1 : 2 (metal : ligand) for complex 1,
whereas 1 :1 :1 (metal : ligand : phen) for complex 2. Physical
property and analytical data of newly synthesized imine base
and its complexes are summarized in the experimental section.
)e molar conductance values at the 10−3·M concentration are
too low to account for any dissociation of the complex in DMF
and are presented in Table 1. Hence, the synthesized VO(IV)
complexes may be regarded as nonelectrolytes. Structural
elucidation of the complexes by multispectroscopic tech-
niques reveals that the vanadium center in complex 1 is
coordinated to two bidentate imine-based ligands with the
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two nitrogen and two phenolate oxygen atoms in equatorial
positions and oxooxygen in the axial position to complete
the square pyramidal N2O3 coordination sphere. Similarly,
N3O2 coordination sphere can be seen around vanadium in
complex 2.
3.1.1. Molar Conductivity Measurements and Magnetic Sus-
ceptibility Measurements. )e metal complexes were dis-
solved in DMSO, and the molar conductivities of their
solutions at 25± 2°C were measured. It is concluded from the
results obtained in Table 1, that the complexes have molar
conductance value of 10.4–13.9 ohm−1·mol−1·cm−1, indicating
that all the complexes are nonelectrolytes. )e magnetic sus-
ceptibility measurements of the complexes were carried out to
ﬁnd out the eﬀective magnetic moment per each metal in the
complexes.)e number of unpaired electrons possessed by the
metal ion can be determined from the eﬀective magnetic
moment of the metal ion. )e magnetic susceptibility studies
from the literature show that VO(IV) complexes have para-
magnetic behavior. Values of magnetic susceptibility (µeﬀ) for
the VO(IV) complexes are given in Table 1. A mononuclear
oxidovanadium(IV) structure is assigned to both complexes 1
and 2, and the µeﬀ values for these complexes are found to be
1.75 and 1.79 BM, respectively. )ese values are well suited for
complexes of oxidovanadium(IV), d1 system [19, 20].
3.1.2. Electronic Spectra. )e electronic absorption spectra of
both the complexes were recorded for the freshly prepared
solution in DMSO at room temperature over the range 200–
800nm, and the spectral data are listed in Table 1.)e electronic
spectra of the complexes in which intense absorptions in the
region of 328–413nm are assigned to the spin allowed intra-
ligand (π–π∗ and n–π∗) and ligand-to-metal charge transfer
(LMCT) O(π)→V(d) transitions.)e weak shoulder appeared
around 490 (486–518) and ∼580nm are due to the d-d tran-
sitions 2B2 (dxy→ dxz, dyz)→ 2E and 2B2 (dxy→ dx2−y2)→ 2B1 in
vanadium complexes which are consistent with the square
pyramidal geometry around the V4+ ion [21, 22]. )e third
absorption is not observed as it might bury beneath the high-
intensity charge transfer band. )e expected d-d transition
band could not be determined, possibly due to a low con-
centration of the vanadium(IV) ion in the samples.
3.1.3. IR Spectra. )e characteristic IR spectral bands of ligand
and its complexes are presented in Table 2. )e IR spectrum of
the ligand shows a strong band at 1037 cm−1 region which is
assigned to the cyclic–OCH3 group of o-vanillin. )e band for
stretching frequency of phenolic OH occurred at 1267 cm−1,
whereas in IR spectrum of these complexes, this band is shifted
to diﬀerent frequency showing a strong band at around
1258–1271 cm−1 region. It indicates that there existed M-O
bond formation and it involved in coordination with the metal
ion. In the spectrum of the Schiﬀ base, the strong bands at
1666 cm−1 region are attributed to -C�N groups in the free
ligand. On chelation, due to the possible drift of lone pair
electron density towards the metal ion, the azomethine -C�N
band is expected to absorb at a lower frequency in the com-
plexes. )e band shifted to 1658–1637 cm−1 region indicating
the coordination of azomethine nitrogen to the metal. Spectra
of the complexes also show new peaks at around 413–452 cm−1
and 493–552 cm−1 region due to the formation of M-O and
M-N bands, respectively. In addition to other bands, the
oxidovanadium complex shows its characteristic V�O fre-
quency at 980 and 967 cm−1 regions for complexes 1 and 2 [23].
3.1.4. Cermogravimetric (TG)/Diﬀerential Cermogravi-
metric Analysis (DTA). of the complexes was carried out
under argon ﬂow in the temperature range of 30–900°C. )e
thermal data of compounds are listed out in Table 3. )e
thermal stability curve of C1 (Figure 1) where decomposition
starts with loss of two coordinated organic ligands in C1 in
the range of 300–513°C and the associated weight loss found
(46.8–97%) is consistent with the calculated values. )ere is
an exothermal peak on the DTA curve in the range of
450–600°C corresponding to the signiﬁcant weight loss of
the ligand moiety of C1. Similarly, compound C2 showed
two-step of condensation in the thermogram where phe-
nanthroline decomposition occurred at a temperature
(105–126°C) lower than that of the ligand (321–394°C). )e
percentage of the ﬁnal metal oxide (V2O5) residue of both
the complexes was calculated from the weight of the ash
obtained.
3.1.5. ESR Spectra. )e complexes C1 and C2 were also
characterized by ESR spectral measurement recorded at
liquid nitrogen temperature in the DMSO solution. )e
X-band ESR spectra of one representative complex in DMSO
at liquid nitrogen temperature are given in Figure 2, whereas
each spectrum shows a hyperﬁne pattern of typical eight
equidistant lines originating from the interaction of an
unpaired electron with 51V, I� 7/2 )ese characteristic
spectral features are indicative of monomeric VO(IV)
complexes.
)e calculated ESR parameters from the spectra of both
the complexes are listed in Table 4.
gavg corresponds to the isotropic giso value was calcu-
lated to be 1.952 and 1.958 for C1 and C2, respectively. )e
parameters showing the orders of g||<g⊥ and A||>>A⊥
indicate that an unpaired electron is present in the (dxy)1
orbital with a square pyramidal geometry around the oxi-
dovanadium(IV) complexes in C4v symmetric fashion
[5, 24]. Within the limits of errors, the experimental A||
agrees with the calculated one, suggesting that the solution
structure at low temperature does not signiﬁcantly deviate
from the structure in the solid state.
Table 1: Electronic spectra and magnetic moments of the metal
complexes.
Compounds µeﬀ(BM)
Λ
(Ohm−1·cm2·mol−1) Electronic spectralbands (nm)
MLCT d-d transition
C1 1.75 13.9 425 555
C2 1.79 10.4 435 565
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e preceding observations further support the com-
position of the complexes, which is compatible with the
results, obtained by each other methods.
3.2. Biology
3.2.1. Antimicrobial Activity. e antimicrobial activities of
the HL and its complexes have been investigated to show
their impressive level of antimicrobial activity of MIC values
against newly emerging highly drug-resistant pathogens.e
results of in vitro study of the microbicidal activity of the
afresh synthesized complexes against four bacterial strains
(Gram negative: E. coli and B. subtilis and Gram positive: S.
aureus and P. aeruginosa) and two fungal strains (A. niger
and C. albicans) are reported in Table 5.
e free ligand HL and its VO(IV) complexes show
varying degree of inhibition eects toward all the organisms,
bacteria, and fungi. It is evident that the metal coordination
tends to make the ligands strong bacteriostatic and fungistatic
agents and e®ciently inhibits both bacterial cell and mycelial
growth of drug-resistant microbes more than the parent li-
gand. e oxidovanadium(IV) complex C2 of mixed ligands
showed good antifungal activity rather than antibacterial than
the free ligand and is almost nearer to the standard drugs used.
e minimum inhibitory concentration (MIC) of com-
pounds, which showed signi­cant activity against bacterial and
fungal species, was also determined (Table 6).eMIC of these
compounds varies from 10 to 100mg/mL.e results indicated
that these compounds were the most active in inhibiting the
growth of the tested species at 10mg/mL concentration.
ese results show the structure activity relationship
between the organism and the substituted saline moiety. e
inhibition values indicate that most complexes have higher
percentage towards Gram-negative bacteria compared to
Gram positive is due to the metal ions shared with the donor
atoms (N and O) of the ligand and the pi-electron de-
localization over the chelate ring increases electron density
over CN nitrogen leading to strong interactions with cell
constituents. Such increased activity of the metal chelates
can be explained on the basis of the oxidation state of the
metal ion and chelation theory (Tweedy’s and Overtone’s
concept) [20, 25].
Mechanism of action seems that the structural compo-
nents possessing additional azomethine linkage with het-
eroatoms inhibit enzyme activity due to their deactivation by
metal coordination. is permits their e®cient membrane
permeabilizing ability through the lipoid layer of organisms
and destroys their activity [26]. e enhanced antimicrobial
potency of the complexes may also be explained by their sol-
ubility, conductivity, ­tness of the particles, cell permeability, size
of the metal ion, and bond length between metal and ligand.
Membrane-targeting antibiotics will exhibit charge-
based selectivity toward the bacterial membrane. In gen-
eral, Gram-positive bacteria have a simpler cell wall than
Gram-negative bacteria, and the primary constituent is
peptidoglycan, a polysaccharide. In contrast, Gram-negative
bacteria have an additional outer bilayer membrane com-
posed of lipopolysaccharides and phospholipids [27, 28].
(1) Time-Dependent Kinetics. Killing kinetics exhibited
marked eectmade by complexes than free ligand on bacterial
strain chosen. e control showed no noticeable bactericidal
activity throughout 24 h incubation for all the compounds
performed.e ligand HL (Figure 3(a)) at 0.5×MIC showed
no signi­cant eect on E. coli up to 18 h, and after that, it
showed a slow decline up to 24 h. At 1× and 2× theMICs, the
rate of killing increased with increasing incubation time
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Figure 1: TGA-DTA thermogram of complex 1.
Table 3: TGA analysis of synthesized compounds.
Serial
number Compounds Stages
Temperature
range (TG) (°C)
Probable composition
of expelled group/s
Weight loss found (%) No. of
molecules
%
residue NatureCal. Expt.
1 C1 I 302–513 HL 91.2 93.3 2 8.7 V2O5
2 C2
I 105–126 1,10-phen 24.4 23.6 1 12.6 V2O5
II 321–394 HL 47.0 46.2 1
Table 2: Important infrared frequencies (cm−1) of HL and its complexes.
Complexes ν (CN) ν (pH-OH) ν (OCH3) ν (VO) ν (M-N) ν (M-O)
HL 1666 1267 1019 — — —
Complex 1 1658 1271 1083 980 544 448
Complex 2 1653 — 1025 967 507 452
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and reached ∼1× 103 and ∼1× 102 CFU·mL−1, respectively.
Time-kill curve for complex C2 is displayed in Figures 3(b)
and 3(c) against E. coli. When a mild activity was observed at
0.5×, the rate of killing was gradually increased with time
and complete killing occurred at 2× the MIC. Complexes C1
and C2 showed a more or less similar kind of killing kinetics
which showed modest activity at 1× and 2× the MIC.
3.2.2. Antioxidant Activity. Oxidovanadium(IV) complexes
exhibit good DNA-binding aﬃnity, and it is considered
worthwhile to study the antioxidant activity of these com-
pounds. Free radicals play a vital role in the pathogenesis of
various human diseases and aging. In food products, free
radicals also cause damage, resulting in diminishing taste
and shelf life. Antioxidants are therefore protecting against
free radicals and save health. Mostly, strong antioxidant
activity is shown by polyphenols. Our study aimed at ex-
ploring the most potent antioxidant and examining the
factors that give a picture and establish the antioxidant
activity with frequent comparison to diﬀerent concentra-
tions of HL and its VO(IV) complexes (Figure 4).)e results
revealed that ligand showed low-scavenging potential
(∼20.32–49.78%) in all the screened concentrations; how-
ever, upon complexation with oxidovanadium ions, anti-
oxidant activity has been enhanced signiﬁcantly (∼70–73%)
through oxidation of V(IV)O2+ to V(V)O+ using water as
a medium in the reaction mixture since assay was run in the
methanolic system [29]. It is believed that the large con-
jugated system and chelation of the organic molecules with
the metal ions by nitrogen and phenolic hydroxyl group
beneﬁts the trapping of free radicals. It is further supported
by the observed discoloration from purple DPPH radical
solution to yellow solution showing scavenging of the DPPH
radicals by hydrogen donation.
3.2.3. DNA Binding Study
(1) Electronic Absorption Spectral Features of CT-DNA
Binding. Electronic absorption spectroscopy is one of the
most useful techniques in DNA-binding studies since the
observed changes in the spectra may indicate the mode of
interaction.
)e UV–Vis titration of both complexes in the absence
and in the presence of CT-DNA has been studied in Tris-
buﬀer medium. )e absorption spectra of complexes (at
a constant concentration of complexes and a wavelength
It's a spike
222.601 (mT) 322.601 (mT) 422.601 (mT)
FREQ = 9131.097 (MHz)
Power = 0.99500 (mW)
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–2048
2047
Figure 2: ESR spectrum of C2 in DMSO at liquid nitrogen temperature.
Table 4: ESR spectral data of oxidovanadium(IV) complexes in
DMSO at liquid nitrogen temperature.
Complexes g|| g⊥ gavg A||(×104·cm−1) A⊥(×104·cm−1)
C1 1.9302 1.9736 1.952 158.8 53
C2 1.9310 1.9864 1.958 154.6 54
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range of 800–200 nm) are given in Figure 5. An increase in
the concentration of CT-DNA causes hypochromism for the
high-energy absorption intensity band of complex 1 at
218 nm, and on the contrary, the low energy band at 269 nm
shows the same with DNA addition. A similar pattern has
been observed for the complex 2 at ∼218–231 nm (218, 221,
224, and 231 nm), which exhibits hypochromism and
a signi­cant bathochromism of about 12 nm. ese spectral
Table 5: Antimicrobial results of HL and its metal complexes.
Serial
number
Compounds
(30 µg/disc)
% growth inhibition in µg/mL concentration
Gram-negative bacteria Gram-positive bacteria Fungi
E. coli P. aeruginosa B. subtilis S. aureus C. albicans A. niger
100 50 10 100 50 10 100 50 10 100 50 10 100 50 10 100 50 10
1 HL 16.3 14.8 9.3 48.6 37.1 28.2 47.3 35.3 27.6 23.6 16.7 10.5 40.2 36.6 34.3 41.3 35.5 30.2
2 C1 67.2 52.2 42.1 66.7 51.8 38.2 68.6 54.6 42.2 67.4 51.1 46.3 79.3 57.5 36.5 62.1 54.3 39.4
3 C2 73.8 46.3 36.9 61.3 45.2 32.5 77.5 63.2 36.4 73.7 43.7 32.6 70.2 53.6 41.1 87.6 42.5 41.8
4 Ciprooxacin 96.4 88.2 69.6 85.8 72.9 50.8 92.5 74.6 66.5 91.6 79.5 61.2 — —
5 Fluconazole — — — — 98.6 81.6 72.3 88.2 80.3 66.3
6 Negative control(DMSO) 100 100 100 100 100 100
Each value was replicated thrice.
Table 6: Minimum inhibitory concentration (mg/mL) of compounds against bacteria and fungi.
Serial number Compounds E. coli P. aeruginosa B. subtilis S. aureus C. albicans A. niger
1 HL 15 25 30 15 30 22
2 C1 20 15 10 10 20 30
3 C2 10 20 15 20 10 10
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Figure 3: Time-course kinetics of the bactericidal activity of (a) HL, (b) C1, and (c) C2 on E. coli after exposure to 0.5×, 1×, and 2× the MIC
and the control group treated with normal saline.
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characteristics are typical complexes to have higher binding
propensity with DNA most likely through a stacking mode
of interaction between the planar aromatic chromophore
and the DNA base pairs. To further elucidate the binding
strength of the complexes, intrinsic binding constants Kbin
were calculated by monitoring the changes of absorbance in
the MLCT bands with increasing amounts of CT-DNA. e
binding constant (Kbin) values of complexes are quanti­ed
from (1), and the values found to be 5.95×105, 9.86×106 and
5.61× 103 for complexes C1, C2, and HL, respectively. e
obtained Kbin values of the complexes are almost parallel to
those reported for the typical classical intercalator ethidium
bromide (Kbin, 106–107·M−1) and suggests that the binding
mechanism of oxidovanadium complexes with DNA is
going through the intercalative mode, while the intercalative
ability of nonplanar ligand to DNA appears weak and
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Figure 4: Antioxidant activity of the imine-based ligand (HL) and its metal complexes.
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suggests that ligand is involved in DNA groove binding. e
relative Kbin value and pronounced hyperchromism of
complexes C2 in comparison to C1 with respect to CT-DNA
were owing to the planar and larger surface area of the
1,10-phenanthroline ring appended deeply in the complex
cause enlargement of size of the DNA.
It also suggested that the DNA-binding a®nities of these
oxidovanadium complexes are associated with the electronic
eects of the substituents introduced on the benzene ring of
the ligands. e imine-based ligand would encourage partial
intercalation of compounds in the minor groove of DNA
helices by engaging in hydrogen-bonding interactions be-
tween coordinated –NH– and –OH bands with the func-
tional groups positioned on the edge of DNA bases [30].
(2) Fluorescence Emission Titrations for DNA Interaction.
Fluorescence quenching tendency is further examined to
ascertain the relative binding mode of oxidovanadium
complexes with CT-DNA due to high sensitivity and se-
lectivity of this method [31]. e oxidovanadium complexes
either in aqueous solution or the presence of CT-DNA do
not exhibit any uorescence emission. So, the interaction
of the complexes to DNA has been studied by the competitive
ethidium bromide (EB) binding assay.
Successive addition of the DNA solution into a constant
concentration of complexes led to changes in the uores-
cence intensity of complexes. Quenching of uorescence
intensity of compounds was observed and is displayed
in Figure 6. e uorescence spectra of complex 1 showed
the emission band at λem 486 nm, and in complex 2, the
emission band was observed at 656 nm when excited at
wavelength λex 350 nm and 620 nm, respectively.e intense
uorescence of the DNA-EB complex system can be
quenched by the addition of a third molecule which can bind
DNA by the intercalative mode by displacing EB. is
signi­cant decrease in uorescence intensity aords strong
support in favor of an intercalative binding pattern of the
complex into the DNA double helix.
Furthermore, the uorescence quenching study in the
presence of the complexes was analyzed by the Stern–
Volmer quenching constant (Ksv). e obtained SV plots are
linear (Figure 6), and the values are found to be 1.09
(±0.02)× 104·M−1 for complex 1 and 3.25 (±0.01)× 104·M−1
at 37°C. Hence, the uorescence quenching has static
mechanism as the uorophore, and the quencher collides
together in the ground state. e values of Kq obtained for
DNA was about 1012·M−1·S−1. is again proves that the
uorescence quenching of the biomolecule occurs by the
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Figure 6: Fluorescence quenching curves of EB-DNA in the presence of complex (C1 and C2) at the concentration 0–35 μMat the interval of
5 in Tris-HCl/NaCl buer (pH 7.2). e arrow indicates the eect of increasing the complex concentration on the uorescence emission of
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static mode since kq values are higher than limiting diusion
constant of the diusional quenching for biopolymers
(2∗1011·M−1·S−1).
(3) Viscosity Measurements. e most critical, least ambig-
uous, and eective means to analyze the binding mode of
compounds to DNA is the viscometry technique in solution
can be carried out in the absence of X-ray structural data. A
classical intercalation probe (EB) between the two strands of
DNA results in signi­cant increase in viscosity of the DNA
solution due to an increase in separation of base pairs at the
intercalation sites and hence, an increase in overall DNA
length. In contrast, partial, nonclassical intercalation of li-
gand could crook the DNA helix, resulting in shortening of
DNA length and, concomitantly, reducing its viscosity [32].
e thickness of CT-DNA increases with increase in the
ratio of complexes to CT-DNA is associated with the speci­c
intercalation binding mode [28]. Also, the eects of relative
viscosity of CT-DNA under the inuence of increasing
amounts of the complexes at 26± 0.1°C (Figure 7) resemble
the binding mode of ethidium bromide to DNA. It can be
deduced that the obtained results were parallel to the above
UV-spectroscopic data such as hypochromism and red-shift
of complexes in the presence of DNA.
4. Conclusion
In the present investigation, the synthesis, spectral charac-
terization, in vitro biopotency studies of VO(IV) complexes
of imine-based ligand (HL) were carried out. Elemental
analysis con­rms the stoichiometry in complexes. Physical
properties like molar conductivity, IR, magnetic suscepti-
bility, and electronic spectral properties gave satisfactory
analytical data coupled with ESR, and TGA studies suggested
the nature of coordination for both the oxidovanadium(IV)
complexes to be square pyramidal geometry with point
group C4V. e synthesized compounds had a broad spec-
trum of antimicrobial activity against a panel of highly
resistant G −ve, G +ve, and fungal pathogens which showed
that the complexes have better antibiotic action than its
parent ligand and standard drugs used. e antioxidant
activity of the complexes found to be as a good scavenger of
DPPH radical comparing to free ligand. Spectral titration
assessed that the metal complexes strongly bind with DNA
relative to the ligand, and the results are corroborated with
each other techniques.
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